134 related articles for article (PubMed ID: 818014)
1. Antiviral activity of Brucella abortus preparations; separation of active components.
Feingold DS; Keleti G; Youngner JS
Infect Immun; 1976 Mar; 13(3):763-7. PubMed ID: 818014
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.
Youngner JS; Keleti G; Feingold DS
Infect Immun; 1974 Dec; 10(6):1202-6. PubMed ID: 4373393
[TBL] [Abstract][Full Text] [Related]
3. Overview of the activity of a Brucella abortus preparation, Bru-Pel.
Youngner JS; Feingold DS; Keleti G
Cancer Treat Rep; 1978 Nov; 62(11):1915-8. PubMed ID: 728911
[TBL] [Abstract][Full Text] [Related]
4. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
[TBL] [Abstract][Full Text] [Related]
6. Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens.
Bae JE; Schurig GG; Toth TE
Vet Microbiol; 2002 Aug; 88(2):189-202. PubMed ID: 12135637
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of Th1 memory responses against a Brucella abortus conjugate.
Scharf O; Agranovich I; Lee K; Eller NL; Levy L; Inman J; Scott DE; Golding B
Infect Immun; 2001 Sep; 69(9):5417-22. PubMed ID: 11500412
[TBL] [Abstract][Full Text] [Related]
8. Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.
Sanakkayala N; Sokolovska A; Gulani J; Hogenesch H; Sriranganathan N; Boyle SM; Schurig GG; Vemulapalli R
Clin Diagn Lab Immunol; 2005 Dec; 12(12):1429-36. PubMed ID: 16339067
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
[TBL] [Abstract][Full Text] [Related]
11. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
[TBL] [Abstract][Full Text] [Related]
12. Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.
Pugh GW; Tabatabai LB
Infect Immun; 1996 Feb; 64(2):548-56. PubMed ID: 8550206
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the protective and cross-reacting antigens of Brucella spp., Yersinia enterocolitica 0:9 and Salmonella serotypes of Kauffmann-White group N.
Corbel MJ
Contrib Microbiol Immunol; 1979; 5():50-63. PubMed ID: 119612
[TBL] [Abstract][Full Text] [Related]
14. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
Tabynov K; Yespembetov B; Ryskeldinova S; Zinina N; Kydyrbayev Z; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
Vaccine; 2016 Jan; 34(4):438-444. PubMed ID: 26709638
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of a canine brucellosis vaccine candidate based on live attenuated Salmonella expressing recombinant Brucella BCSP31, Omp3b and SOD proteins in Beagles.
Kim WK; Moon JY; Cho JS; Park BY; Hur J
J Vet Med Sci; 2018 Sep; 80(9):1373-1379. PubMed ID: 30068897
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.
Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
Infect Immun; 1979 Jan; 23(1):19-26. PubMed ID: 106004
[TBL] [Abstract][Full Text] [Related]
17. Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice.
Winter AJ; Rowe GE
Vet Immunol Immunopathol; 1988 Mar; 18(2):149-63. PubMed ID: 3133872
[TBL] [Abstract][Full Text] [Related]
18. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
Goel D; Rajendran V; Ghosh PC; Bhatnagar R
Vaccine; 2013 Feb; 31(8):1231-7. PubMed ID: 23273966
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S
Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487
[TBL] [Abstract][Full Text] [Related]
20. Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.
Delpino MV; Estein SM; Fossati CA; Baldi PC
Clin Vaccine Immunol; 2007 Oct; 14(10):1296-301. PubMed ID: 17715332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
